x
Filter:
Filters applied
- Multimedia LibraryRemove Multimedia Library filter
- DiabetesRemove Diabetes filter
Publication Date
Please choose a date range between 2005 and 2019.
Author
- Alamo, Munir1
- Arterburn, David1
- Baez, Percy Brante1
- Bock, Steven N1
- Cummings, David E1
- Dixon, John B1
- Flum, David R1
- Fuller, Sharon1
- Galvao Neto, Manoel Passos1
- Hsin, Ming-Che1
- Huang, Chih-Kun1
- Kowalski, Katie1
- Landers, Jeffrey1
- Liu, Chia-Chia1
- Mary Shea, MA1
- Nor Hanipah, Zubaidah1
- Ponce, Jaime1
- Ramos, Almino Cardoso1
- Rodriguez-Grunert, Leonardo1
- Tarnoff, Michael1
- Turnbull, Emily1
- Westbrook, Emily O1
Multimedia Library
4 Results
- Original article
Laparoscopic loop duodenaljejunal bypass with sleeve gastrectomy in type 2 diabetic patients
Surgery for Obesity and Related DiseasesVol. 15Issue 5p696–702Published online: January 25, 2019- Zubaidah Nor Hanipah
- Ming-Che Hsin
- Chia-Chia Liu
- Chih-Kun Huang
Cited in Scopus: 2Diabetes is an epidemic disease and is estimated to affect >300 million people worldwide in 2025 [1]. Type 2 diabetes (T2D) management is a combination of diet, lifestyle modifications, and drug therapy. Recently, many studies have shown remission of T2D in obese population [2–6]. Buchwald et al. [2] in his systemic review and meta-analysis showed that diabetes remission rates were 99% (95% confidence interval, 97%–100%) after biliopancreatic diversion, 84% (95% confidence interval, 77%–90%) after Roux-en-Y gastric bypass (RYGB), and 48% (95% confidence interval, 29%–67%) after gastric banding. - Original article
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes
Surgery for Obesity and Related DiseasesVol. 9Issue 6p837–844Published online: June 6, 2013- David Arterburn
- David R. Flum
- Emily O. Westbrook
- Sharon Fuller
- M.A. Mary Shea,
- Steven N. Bock
- and others
Cited in Scopus: 18Randomized trials of bariatric surgery versus lifestyle treatment likely enroll highly motivated patients, which may limit the interpretation and generalizability of study findings. The objective of this study was to assess the feasibility of a population-based shared decision-making (SDM) approach to recruitment for a trial comparing laparoscopic Roux-en-Y gastric bypass surgery with intensive lifestyle intervention among adults with mild to moderate obesity and type 2 diabetes. - Original article with video
First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve
Surgery for Obesity and Related DiseasesVol. 4Issue 1p55–59Published in issue: January, 2008- Leonardo Rodriguez-Grunert
- Manoel Passos Galvao Neto
- Munir Alamo
- Almino Cardoso Ramos
- Percy Brante Baez
- Michael Tarnoff
Cited in Scopus: 167We report the first human experience with an endoscopic duodenal-jejunal bypass sleeve (DJBS) in a community hospital. - 2004 ASBS Consensus Conference
Laparoscopic adjustable gastric banding
Surgery for Obesity and Related DiseasesVol. 1Issue 3p310–316Published in issue: May, 2005- Jaime Ponce
- John B. Dixon
Cited in Scopus: 18Laparoscopic adjustable gastric banding (LAGB) brings several unique aspects to bariatric surgery. It has provided a very safe, effective, reversible, and adjustable system that is widely applicable. The first human LAGB procedure, using the Lap-Band system (INAMED Health, Santa Barbara, CA), was performed on September 1, 1993 [1]. Since then, more than 130,000 Lap-Band devices have been placed, and more than 100 peer-reviewed reports on its use have been published. The extent of the literature on the outcomes of LAGB surgery is comparable (and, in certain aspects, superior) to that on alternative bariatric surgery.